Search
| (ENZN) NASDAQ | |||
| Last Trade | 9.82 | ||
| Change(%) | ![]() | +0.01 | |
| Volume | 261532 | ||
| 1:18 PM - Mar 09, 2010 | |||
News
Enzon to Present at NewsMakers in the Biotech Industry Conference
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
Enzon to Present at BMO Focus on Healthcare Conference
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director

Cimzia®, Utilizing Enzon's PEGylation Technology, Approved in the U.S.
Enzon's HIF-1 alpha Antagonist Shows Antitumor Activity
--Innovative and diverse pipeline advances--
Enzon Pharmaceuticals Announces Intention to Explore Strategic Alternatives for Specialty Pharmaceuticals Business
-- Enzon Continues to Pursue Plan to Spin-off Biotechnology Business --
Enzon Pharmaceuticals Commences Tender Offer For a Portion of its Debt

Enzon Reveals New LNA Targets
-- Data will be presented at upcoming American Association for Cancer Research Meeting--
Enzon to Present at BMO Capital Markets Focus on Healthcare Conference
Enzon Pharmaceuticals Commences Tender Offer For a Portion of its Debt
Enzon's HIF-1 alpha Antagonist Shows Antitumor Activity
--Innovative and diverse pipeline advances--
